Non Vascular Stent Market to Reach $2.7 billion, Globally, by 2035 at 4.5% CAGR

According to the report, the "non vascular stent market" was valued at $1.6 billion in 2023, and is estimated to reach $2.7 billion by 2035, growing at a CAGR of 4.5% from 2024 to 2035.

Request Sample of the Report on -

https://www.alliedmarketresearch.com/request-sample/A324064

Rise in adoption of minimally invasive surgical procedures and presence of key players that drive the growth of the global non vascular stent market. However, regulatory compliance is anticipated to hinder the market growth. On the contrary, rise in technological advancements is expected to offer remunerative opportunities for the non vascular stent market during the forecast period.

Connect to our Analyst -

https://www.alliedmarketresearch.com/connect-to-analyst/A324064

The urological stents segment maintained its lead position during the forecast period.

Based on product type, the urological stents segment accounted for the largest share in 2023, accounting for more than one-third of the global non vascular stent market revenue. This dominance is attributed to rise in prevalence of urological disorders such as kidney stones, ureteral strictures, and benign prostatic hyperplasia (BPH). The increasing adoption of minimally invasive procedures, advancements in stent design improving biocompatibility and durability, and growing awareness among healthcare professionals further contributed to its market leadership.

The non metallic segment to maintain its lead position during the forecast period.

Based on material type, the non metallic segment accounted for the largest share in 2023, accounting for more than half of the global non vascular stent market revenue and is projected to register highest CAGR of 4.7% during the forecast period. This growth is attributed to rise in demand for biodegradable and polymer-based stents, which minimize long-term complications like inflammation and migration. Their ability to provide temporary support without requiring removal appeals to both patients and providers. Increased focus on patient-centric care, coupled with advancements in material technology and expanding applications, further accelerates the adoption of non-metallic stents.

The hospitals segment to maintain its lead position during the forecast period.

Based on end user, the hospitals segment accounted for the largest share in 2023, accounting for almost two-thirds of the global non vascular stent market revenue. This is attributed to their advanced infrastructure, specialized medical staff, and ability to perform complex procedures, including stent placement, with high precision. Hospitals offer a comprehensive range of services and are equipped with the latest technologies for diagnosing and treating conditions requiring non vascular stents. In addition, hospitals provide better access to post-procedure care and management, contributing to their dominance in the market.

North America to maintain its dominance by 2035

Based on region, North America held the highest market share in terms of revenue in 2023, accounting for almost two-fifths of the global non vascular stent market revenue. This is primarily attributed to its well-established healthcare infrastructure, advanced medical technology, and high healthcare expenditure. The presence of leading market players, favorable reimbursement policies, and rise in aging population contributed to the region's dominance. In addition, North America's strong research and development capabilities, along with high awareness on availability of non vascular stents and adoption of minimally invasive procedures, fueled the market growth.

For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A324064

Leading Market Players

Ella - CS, S.R.O.
Boston Scientific Corporation
Hobbs Medical Inc.
Becton, Dickinson, And Company
W.L. Gore and Associate Inc.
Medtronic Plc
Cook Group
Micro-Tech (Nanjing) Co., Ltd.
Q3 Medical Group
Conmed Corporation

Trending Reports in Healthcare Industry:

Tattoo Removal Market https://www.alliedmarketresearch.com/tattoo-removal-market

Dental Intraoral Camera Market https://www.alliedmarketresearch.com/dental-intraoral-camera-market-A13402

Spinal Muscular Atrophy Treatment Market https://www.alliedmarketresearch.com/spinal-muscular-atrophy-treatment-market-A107144

Patient Simulator Market https://www.alliedmarketresearch.com/patient-simulator-market-A11667

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int'l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

This release was published on openPR.